scholarly article | Q13442814 |
P50 | author | Lyn Gilbert | Q90698221 |
P2093 | author name string | Kaitlin A Tagg | |
Deborah L Couldwell | |||
Jennifer A Donald | |||
Neisha J Jeoffreys | |||
P2860 | cites work | Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial | Q46954398 |
Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin. | Q54359754 | ||
A NEWLY DISCOVERED MYCOPLASMA IN THE HUMAN UROGENITAL TRACT | Q56057554 | ||
Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women | Q21131426 | ||
The Minimal Gene Complement of Mycoplasma genitalium | Q22065573 | ||
Molecular biology and pathogenicity of mycoplasmas | Q24548575 | ||
Induced macrolide resistance in Mycoplasma genitalium isolates from patients with recurrent nongonococcal urethritis | Q24605678 | ||
Association between Mycoplasma genitalium and acute endometritis | Q28206155 | ||
Persistence of Mycoplasma genitalium following azithromycin therapy | Q33382111 | ||
Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics | Q34076727 | ||
Macrolide resistance conferred by base substitutions in 23S rRNA. | Q34106180 | ||
Sexually transmitted diseases treatment guidelines, 2010. | Q34155140 | ||
Mycoplasma genitalium PCR: does freezing of specimens affect sensitivity? | Q34190405 | ||
Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis | Q34245136 | ||
Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure | Q34481060 | ||
Mycoplasma genitalium: another important pathogen of nongonococcal urethritis | Q34520839 | ||
Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial | Q35019879 | ||
Mycoplasma genitalium: from Chrysalis to multicolored butterfly | Q35090137 | ||
Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. | Q35122643 | ||
Associations between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory disease | Q35530456 | ||
Azithromycin failure in Mycoplasma genitalium urethritis | Q35792616 | ||
DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones | Q36047665 | ||
Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient service | Q37849026 | ||
Mycoplasma genitalium is associated with cervicitis and HIV infection in an urban Australian STI clinic population | Q37851970 | ||
Ureaplasma urealyticum is significantly associated with non-gonococcal urethritis in heterosexual Sydney men. | Q37853014 | ||
The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy | Q37853910 | ||
Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis. | Q37856727 | ||
Role of Mycoplasma genitalium and Ureaplasma urealyticum in acute and chronic nongonococcal urethritis | Q37874585 | ||
Association of Mycoplasma genitalium with nongonococcal urethritis in heterosexual men. | Q37875161 | ||
Mycoplasma genitalium in the cervices of Japanese women | Q37882938 | ||
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli | Q39816339 | ||
In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectively | Q41092975 | ||
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR. | Q42111508 | ||
Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance | Q43004634 | ||
Macrolide resistance-associated 23S rRNA mutation in Mycoplasma genitalium, Japan | Q43180518 | ||
Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism. | Q45835656 | ||
Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance | Q46260038 | ||
Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study | Q46340504 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Mycoplasma genitalium | Q1930909 |
P304 | page(s) | 2245-2249 | |
P577 | publication date | 2013-05-08 | |
P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
P1476 | title | Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium | |
P478 | volume | 51 |
Q37836494 | 2016 European guideline on the management of non-gonococcal urethritis |
Q36933110 | A 5' Nuclease Genotyping Assay for Identification of Macrolide-Resistant Mycoplasma genitalium in Clinical Specimens. |
Q37280597 | A Novel SimpleProbe PCR Assay for Detection of Mutations in the 23S rRNA Gene Associated with Macrolide Resistance in Mycoplasma genitalium in Clinical Samples. |
Q37572093 | A cross-sectional study of Mycoplasma genitalium infection and correlates in women undergoing population-based screening or clinic-based testing for Chlamydia infection in London |
Q28554374 | Antimicrobial Susceptibility Patterns of Recent Cuban Mycoplasma genitalium Isolates Determined by a Modified Cell-Culture-Based Method |
Q38772340 | Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium |
Q37382490 | Bacterial Load in Daily Urine Samples of Patients Infected with Mycoplasma genitalium, Mutation Analysis, and Response to Treatment |
Q37844311 | Cervicitis of unknown etiology |
Q30235030 | Chlamydia trachomatis Genital Infections |
Q38609853 | Developing a Public Health Response to Mycoplasma genitalium |
Q37844334 | Diagnosis and antimicrobial treatment of Mycoplasma genitalium infection: sobering thoughts |
Q37713726 | Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis |
Q35673469 | Drug resistance-associated mutations in Mycoplasma genitalium in female sex workers, Japan |
Q38646438 | Efficacy of Antimicrobial Therapy for Mycoplasma genitalium Infections |
Q42319628 | Evaluation of a Commercial Multiplex Quantitative PCR (qPCR) Assay for Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance-Associated Mutations in Clinical Specimens |
Q42339724 | Fluoroquinolone-Resistant Mycoplasma genitalium, Southwestern France |
Q40099689 | French Prospective Clinical Evaluation of the Aptima Mycoplasma genitalium CE-IVD Assay and Macrolide Resistance Detection Using Three Distinct Assays. |
Q40917407 | High levels of macrolide resistance-associated mutations in Mycoplasma genitalium warrant antibiotic susceptibility-guided treatment. |
Q37579937 | High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options. |
Q40346692 | High prevalence of the A2058T macrolide resistance-associated mutation in Mycoplasma genitalium strains from the Netherlands |
Q40103287 | In Vitro Activities of Gepotidacin (GSK2140944) and Other Antimicrobial Agents Against Human Mycoplasmas and Ureaplasmas |
Q33597030 | Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium |
Q37839814 | Large two-centre study into the prevalence of Mycoplasma genitalium and Trichomonas vaginalis in the Netherlands |
Q57035503 | Long duration of asymptomatic Mycoplasma genitalium infection after syndromic treatment for nongonococcal urethritis |
Q48537471 | Macrolide and fluoroquinolone resistance in Mycoplasma genitalium in two Swedish counties, 2011-2015. |
Q64239107 | Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007-2014 |
Q41583528 | Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens |
Q64999477 | Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014-2017. |
Q59799969 | Macrolide-resistant Mycoplasma genitalium infections in Cuban patients: an underestimated health problem |
Q26796722 | Management of Mycoplasma genitalium infections - can we hit a moving target? |
Q24658574 | Mass drug administration of azithromycin for trachoma reduces the prevalence of genital Chlamydia trachomatis infection in the Solomon Islands |
Q92755899 | Multicenter Clinical Evaluation of a Novel Multiplex Real-Time PCR (qPCR) Assay for Detection of Fluoroquinolone Resistance in Mycoplasma genitalium |
Q53812158 | Multidrug-Resistant Mycoplasma genitalium Is Increasing. |
Q40271087 | Multidrug-resistant Mycoplasma genitalium infections in Europe |
Q55234408 | Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains. |
Q92798143 | Mycoplasma genitalium Antimicrobial Resistance in Community and Sexual Health Clinic Patients, Auckland, New Zealand |
Q58699936 | Mycoplasma genitalium in the Far North Queensland backpacker population: An observational study of prevalence and azithromycin resistance |
Q27021073 | Mycoplasma genitalium infection: current treatment options, therapeutic failure, and resistance-associated mutations |
Q42355223 | Mycoplasma genitalium infections: current treatment options and resistance issues |
Q40063952 | Mycoplasma genitalium macrolide and fluoroquinolone resistance detection and clinical implications in a selected cohort in New Zealand |
Q35008363 | Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey |
Q40071934 | Mycoplasma genitalium: Accurate Diagnosis Is Necessary for Adequate Treatment |
Q26748959 | Mycoplasma genitalium: An Emerging Sexually Transmitted Infection |
Q26747053 | Mycoplasma genitalium: An Overlooked Sexually Transmitted Pathogen in Women? |
Q28910390 | N-Terminal Polypeptide of Annexin A2 Decreases Infection of Mycoplasma hyorhinis to Gastric Cancer Cells |
Q38609857 | New Horizons in Mycoplasma genitalium Treatment |
Q37833830 | Prevalence and antibiotic resistance of Mycoplasma genitalium among STI clinic attendees in Western Canada: a cross-sectional analysis |
Q33562762 | Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia |
Q97075329 | Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis |
Q28647996 | Prevalence of sexually transmitted infections in female clinic attendees in Honiara, Solomon Islands |
Q42212384 | Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan. |
Q59296685 | Reply to Deguchi et al |
Q34479272 | Sexually transmitted diseases treatment guidelines, 2015. |
Q38560388 | The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis |
Q35052845 | Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin |
Q64098896 | Turning the Tide against Antibiotic Resistance by Evaluating Novel, Halogenated Phenazine, Quinoline, and NH125 Compounds against Species Clinical Isolates and Type Strains |
Q37839072 | Ureaplasma parvum and Mycoplasma genitalium are found to be significantly associated with microscopy-confirmed urethritis in a routine genitourinary medicine setting |
Search more.